Cost-utility analysis of a nationwide vaccination programme against serogroup B meningococcal disease in Israel. [electronic resource]
- International journal of public health Jul 2016
- 683-692 p. digital
Publication Type: Journal Article
1661-8564
10.1007/s00038-016-0821-0 doi
Adolescent Child Child, Preschool Cost-Benefit Analysis Female Humans Immunization Programs--economics Infant Israel Male Meningococcal Infections--economics Models, Economic Neisseria meningitidis, Serogroup B--immunology Quality-Adjusted Life Years Vaccination--economics